As of March 2023 Sangamo Therapeutics has a market cap of $0.32 Billion. This makes Sangamo Therapeutics the world's 5701th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Year | Market cap | Change |
---|---|---|
2023 | $0.32 B | -36.27% |
2022 | $0.51 B | -52.9% |
2021 | $1.09 B | -50.5% |
2020 | $2.20 B | 127.38% |
2019 | $0.97 B | -17.26% |
2018 | $1.17 B | -15.37% |
2017 | $1.38 B | 543.51% |
2016 | $0.21 B | -66.47% |
2015 | $0.64 B | -38.85% |
2014 | $1.05 B | 21.5% |
2013 | $0.86 B | 171.12% |
2012 | $0.31 B | 113.99% |
2011 | $0.14 B | -50.54% |
2010 | $0.30 B | 13.12% |
2009 | $0.26 B | 86.78% |
2008 | $0.14 B | -72.83% |
2007 | $0.52 B | 126.96% |
2006 | $0.23 B | 87.74% |
2005 | $0.12 B | -18.75% |
2004 | $0.15 B | 11.08% |
2003 | $0.13 B | 83.3% |
2002 | $74.46 M | -67.43% |
2001 | $0.22 B |
On Mar 27th, 2023 the market cap of Sangamo Therapeutics was reported to be:
Name | Market cap | Market cap differencediff. | Country |
---|---|---|---|
![]() Johnson & Johnson JNJ | $473.65 B | 144,335.31% | ๐บ๐ธ USA |
![]() Amgen AMGN | $127.34 B | 38,731.64% | ๐บ๐ธ USA |
![]() Biogen BIIB | $39.04 B | 11,807.03% | ๐บ๐ธ USA |
![]() Dow DOW | $37.45 B | 11,322.90% | ๐บ๐ธ USA |
![]() Gilead Sciences GILD | $101.11 B | 30,734.44% | ๐บ๐ธ USA |
![]() Merck MRK | $267.89 B | 81,592.19% | ๐บ๐ธ USA |
![]() Alnylam Pharmaceuticals
ALNY | $23.40 B | 7,037.05% | ๐บ๐ธ USA |
![]() BioMarin Pharmaceutical BMRN | $16.71 B | 4,996.72% | ๐บ๐ธ USA |